MedTrace Logo

Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing Therapy

NCT02695953 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-10-27

No results posted yet for this study

Summary

Posttraumatic stress disorder (PTSD) is a significant personal and societal burden. The purpose of this study is to examine genetic, epigenetic, behavioral, and brain activity changes related to PTSD dysfunction and recovery before and after treatment with Cognitive Processing Therapy.

Conditions

Sponsors & Collaborators

  • Milissa Kaufman

    lead OTHER

Principal Investigators

  • Milissa L Kaufman, MD/PhD · Mclean Hospital

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02695953 on ClinicalTrials.gov